Tips for Warning Letter Case Studies

During routine operations, a pharmaceutical manufacturing facility observed several alarming indicators suggesting a potential issue with their digital GMP systems. Symptoms identified included:Click to read the full article.

The journey began when the quality control unit noticed a spike in out-of-specification (OOS) results during routine stability testing of a specific drug product. Initial signals included:Click to read the…

Upon receiving an FDA warning letter, our hypothetical scenario reveals several symptoms observed on the production floor of a sterile injectables manufacturing facility. These include:Click to read the full article.